×

Q&A March

Tweet Spring is almost here. If you have an unrelated question, this is the place for you Source: multiple-sclerosis-research.org

Multiple Sclerosis is a F…ing Thief

How do you know? The Northeast Blizzard of 2026 brought blankets, hunkering down, power outtages and spotty internet. What it didn’t bring was new, creative ideas for an MS humor blog. To be fair, I wasn’t really having a ton of ideas before the blizzard…

CD44 a promising Target, MD ahead of his time?

Tweet Aljasir MA. An Integrated Network Biology and Molecular Dynamics Approach Identifies CD44 as a Promising Therapeutic Target in Multiple Sclerosis. Pharmaceuticals. 2026;19:254. Background: Multiple sclerosis (MS) is a neuroinflammatory disease characterized by autoimmune-driven inflammation in the central nervous system that damages axons and destroys myelin.…

Placebo and Glatiramer Acetate Depot

Tweet Glatiramer acetate is the active ingredient in a drug that was originally sold as Trade Name Copaxone, which was invented in Israel in the 1970s as a random mix of 4 amino acids. This was given as a 20mg injection daily. As the patent…

MS Awareness Month events highlight advocacy, education, fundraising

This March, organizations and advocates are marking Multiple Sclerosis Awareness Month with fundraisers, educational events, and other activities to spotlight the disease and its impact on an estimated 1.8 million people worldwide. The annual campaign reaches beyond the general public to include researchers, lawmakers, industry…

Ask the Expert: Visual Disorders

Featuring Barry A. Hendin, MD MSAA’s Chief Medical Officer Question: What types of visual disorders may be caused by MS, and are any types of visual issues not typically associated with MS? Answer: Visual signs and symptoms are common in … Continue reading → Source:…

Controling EBV infection

Tweet Host control of persistent Epstein-Barr virus infection. Schmidt A, Alawathurage TM, David FS, Ogawa Y, Frach L, Richter S, Schaefer M, Mathey CM, Henne SK; Japan COVID-19 Task Force; Forstner AJ, Dilthey AT, Pröbstel AK, Boztug K, Nöthen MM, Namkoong H, Okada Y, Beins…

Antibodies to stop EBV infection. Does ProfG get the tool he wants?

Tweet •Transgenic mice were used to make genetically human EBV mAbs against gp350 and gp42 •mAbs potently neutralize EBV infection by blocking receptor-ligand interactions •mAbs prevent EBV infection following EBV challenge in humanized mice We know that there is interest in stopping EBV and there…

Multiple Sclerosis and faith: the rip in our canvas

Living with Multiple Sclerosis means learning to navigate a body that does not always cooperate. It means wrestling with faith, asking hard questions about God, and redefining independence. With this, there is a metaphor in my head I can’t shake. After a great podcast conversation…